切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2018, Vol. 12 ›› Issue (02) : 120 -122. doi: 10.3877/cma.j.issn.1674-1358.2018.02.004

所属专题: 文献

综述

肝硬化合并皮肤软组织感染研究进展
李聪1, 陈羽婷1, 杨松1,(), 成军1   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院肝病中心肝病三科
  • 收稿日期:2016-12-27 出版日期:2018-04-15
  • 通信作者: 杨松
  • 基金资助:
    北京市卫生系统高层次卫生技术人才培养计划(No.2015-3-108); 北京市医院管理局临床医学发展专项经费资助(No. ZY201402)

Progress on skin and soft tissue infections in patients with liver cirrhosis

Cong Li1, Yuting Chen1, Song Yang1,(), Jun Cheng1   

  1. 1. Division 3 of Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Received:2016-12-27 Published:2018-04-15
  • Corresponding author: Song Yang
  • About author:
    Corresponding author: Yang Song, Email:
引用本文:

李聪, 陈羽婷, 杨松, 成军. 肝硬化合并皮肤软组织感染研究进展[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(02): 120-122.

Cong Li, Yuting Chen, Song Yang, Jun Cheng. Progress on skin and soft tissue infections in patients with liver cirrhosis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2018, 12(02): 120-122.

肝硬化患者因其免疫力低下、下肢水肿等原因是皮肤软组织感染的高危人群,常见的皮肤软组织感染部位为下肢,常见的感染类型为蜂窝织炎。与一般人群不同,肝硬化患者合并皮肤软组织感染的病原体以革兰阴性杆菌为主。血清肌酐值和MELD评分为肝硬化患者合并皮肤软组织感染预后不良的预测因素。我国肝硬化患者合并皮肤软组织的病原学与临床特征尚需进一步明确,旨在为优化此类患者的优化管理提供一定的依据。

Patients with liver cirrhosis are in high risk of skin and soft tissue infections for the compromised immune and edema of lower extremity. Lower extremity is the most common position for skin and soft tissue infection for patients with liver cirrhosis. Cellulitis is the most common type of skin and soft tissue infections for these patients. Gram-negative bacillus are the major pathogens for cirrhosis patients with skin and soft tissue infections, which are different from general population. Serum creatinine level and MELD score are prognosis predictors for these patients. Further studies should be carried out to identify the pathogen, clinical characteristics of skin and soft tissue infections in Chinese patients with liver cirrhosis, in order to provide certain basis for optimizing the management of these patients.

[1]
Pleguezuelo M, Benitez JM, Jurado J, et al. Diagnosis and management of bacterial infections in decompensated cirrhosis[J]. World J Hepatol,2013,5(1):16-25.
[2]
Prado V, Acevedo J, Fernández J. Bacterial Infections in Cirrhosis Prevention and Treatment[J]. Curr Hepatol Rep,2014,13(1):43-49.
[3]
Taneja SK, Dhiman RK. Prevention and management of bacterial infections in cirrhosis[J]. Int J Hepatol,2011,2011:784540.
[4]
Arvaniti V, D’Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis[J]. Gastroenterology,2010,139(4):1246-1256.
[5]
Liu BM, Chung KJ, Chen CH, et al. Risk factors for the outcome of cirrhotic patients with soft tissue infections[J]. J Clin Gastroenterol,2008,42(3):312-316.
[6]
陈迎晓, 龚玲, 王晓东, 等. 肝硬化并发感染的回顾性研究[J]. 中国医师进修杂志,2007,30(10):56-57.
[7]
Assimakopoulos SF, Charonis AS. Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: the pivotal role of enterocyte tight junctions and future perspectives[J]. J Hepatol,2013,59(5):1144-1146.
[8]
Romeo J, Wärnberg J, Marcos A. Drinking pattern and socio-cultural aspects on immune response: an overview[J]. Proc Nutr Soc,2010,69(3):341-346.
[9]
Kakazu E, Ueno Y, Kondo Y, et al. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis[J]. Hepatology,2009,50(6):1936-1945.
[10]
Mohan P, Ramu B, Bhaskar E, et al. Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis[J]. Ann Hepatol,2011,10(1):15-20.
[11]
Corredoira JM, Ariza J, Pallarés R, et al. Gram-negative bacillary cellulitis in patients with hepatic cirrhosis[J]. Eur J Clin Microbiol Infect Dis,1994,13(1):19-24.
[12]
Hamza RE, Villyoth MP, Peter G, et al. Risk factors of cellulitis in cirrhosis and antibiotic prophylaxis in preventing recurrence[J]. Ann Gastroenterol,2014,27(4):374-379.
[13]
Sood A, Midha V, Goyal O, et al. Skin and soft tissue infections in cirrhotics: a prospective analysis of clinical presentation and factors affecting outcome[J]. Indian J Gastroenterol,2014,33(3):281-284.
[14]
Kim JH, Lee JS, Lee SH, et al. Renal dysfunction induced by bacterial infection other than spontaneous bacterial peritonitis in patients with cirrhosis: incidence and risk factor[J]. Gut Liver,2009,3(4):292-297.
[15]
Lin MN, Tsai CC, Hung TH, et al. The risk of cellulitis in cirrhotic patients: a nationwide population-based study in Taiwan[J]. Gut Liver,2012,6(4):482-485.
[16]
Morris A. Cellulitis and erysipelas[J]. Clin Evid,2003,9:1804-1809.
[17]
Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues[J]. N Engl J Med,1996,334(4):240-245.
[18]
Liu BM, Hsiao CT, Chung KJ, et al. Hemorrhagic bullae represent an ominous sign for cirrhotic patients[J]. J Emerg Med,2008,34(3):277-281.
[19]
Preveden T. Bacterial infections in patients with liver cirrhosis[J]. Med Pregl,2015,68(5-6):187-191.
[20]
Wu HS, Wang FD, Tseng CP, et al. Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan[J]. J Infect,2012,64(2):162-168.
[21]
Chang CM, Lee HC, Lee NY, et al. Community-acquired Klebsiella pneumoniae complicated skin and soft-tissue infections of extremities: emphasis on cirrhotic patients and gas formation[J]. Infection,2008,36(4):328-334.
[22]
Maraki S, Christidou A, Anastasaki M, et al. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections[J]. Infect Dis (Lond),2016,48(3):171-176.
[23]
Singal AK, Salameh H, Kamath PS. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States[J]. Aliment Pharmacol Ther,2014,40(1):105-112.
[24]
Pereira G, Guevara M, Fagundes C, et al. Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study[J]. J Hepatol,2012,56(5):1040-1046.
[1] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[2] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[3] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[4] 雷雪雪, 于颖, 李虹彦. 乙型肝炎肝硬化患者肝移植等待期应用多模式预康复优化项目的临床研究[J]. 中华移植杂志(电子版), 2023, 17(03): 158-163.
[5] 李芳, 孙海云. 风险因素护理干预对合并失代偿性肝硬化的腹股沟疝患者Lichtenstein术围手术期应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 477-480.
[6] 张晓贝, 曹栋, 杨宝顺, 俞永江. 肝硬化腹水合并腹股沟疝的临床治疗进展[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 121-124.
[7] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[8] 许语阳, 吕云福, 王葆春. 乙肝后肝硬化门静脉高压症脾肿大外科治疗进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 469-473.
[9] 李勇, 兰川, 吴斌, 张光年, 李敬东. 术前血小板-白蛋白评分对肝硬化肝癌术后预后的预测价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 412-416.
[10] 杨林青, 任松, 纪泛扑, 张健, 蒋安, 张丽, 安鹏, 王林, 李宗芳. 揿针疗法对门静脉高压症脾切除断流术后胃肠功能的调节作用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 322-326.
[11] 朱翔宇, 王建美, 张辉, 叶红英. 无创左心室压力-应变循环技术在左心室功能参数与肝硬化的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 494-498.
[12] 张雯, 宋牡丹, 邓雪婷, 张云. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 456-460.
[13] 秦维, 王丹, 孙玉, 霍玉玲, 祝素平, 郑艳丽, 薛瑞. 血清层粘连蛋白、Ⅳ型胶原蛋白对代偿期肝硬化食管胃静脉曲张出血的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 447-451.
[14] 郭亮亮, 邱珊珊, 钟萍, 赵心恺. 血小板-白蛋白-胆红素评分对肝硬化上消化道出血的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 216-219.
[15] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
阅读次数
全文


摘要